Table 2.
In-hospital outcomes of patients undergoing ERCP in the National Inpatient Sample (2016–2022), weighted for sample design, stratified by high-risk comorbidity status*
| Outcome | No high-risk comorbidity n = 904,234 | High-risk comorbidity n = 267,739 | p-value |
|---|---|---|---|
| Mortality | 7,469 (0.8) | 10,169 (3.8) | < 0.001 |
| Any morbidity | 322,919 (35.7) | 192,359 (71.8) | < 0.001 |
| Neurological complication | 7,939 (0.9) | 7,339 (2.7) | < 0.001 |
| Cardiovascular complication | 76,694 (8.5) | 76,174 (28.5) | < 0.001 |
| Respiratory complication | 36,024 (4.0) | 38,544 (14.4) | < 0.001 |
| Gastrointestinal complication | 78,289 (8.7) | 19,139 (7.1) | < 0.001 |
| Infectious complication | 131,944 (14.6) | 82,019 (30.6) | < 0.001 |
| Wound complication | 32,369 (3.6) | 31,849 (11.9) | < 0.001 |
| Hematological complication | 33,309 (3.7) | 27,814 (10.4) | < 0.001 |
| Venous thromboembolism | 14,539 (1.6) | 8,044 (3.0) | < 0.001 |
| Renal complication | 90,684 (10.0) | 108,959 (40.7) | < 0.001 |
| Resource utilization | |||
| Length of stay, mean ± SD (days) | 5.3 [1.3, 9.2] | 8.5 [2.3, 14.7] | < 0.001 |
| Total cost, mean ± SD (USD) | 30,939 ± 52,624 | 31,426 ± 54,470 | 0.06 |
| Total charges, mean ± SD (USD) | 81,984 ± 96,368 | 122,635 ± 192,900 | < 0.001 |
*High-risk comorbidity defined as presence of chronic kidney disease, chronic heart failure, or liver cirrhosis
Values are n (%) unless otherwise indicated